Kala Pharmaceuticals

Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using its AMPPLIFY? Mucus Penetrating Particles drug delivery technology, with a focus on the treatment of eye diseases. The company's approved ocular corticosteroid product, INVELTYS? (loteprednol etabonate ophthalmic suspension) is used for the treatment of post-operative inflammation and pain. The company is developing KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease. The company is evaluating compounds in its receptor Tyrosine Kinase Inhibitor program that inhibit the vascular endothelial growth factor pathway for the treatment of a number of retinal diseases.
  • TickerKALA
  • ISINUS4831191030
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
 PRESS RELEASE
KALA Kala Pharmaceut... (Health Care)

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rul...

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 92,000 shares of Kala Pharmaceuticals common stock to sixteen new employees. The stock options were granted on July 15, 2021. The grants were ...

Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
 PRESS RELEASE
KALA Kala Pharmaceut... (Health Care)

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rul...

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 92,000 shares of Kala Pharmaceuticals common stock to sixteen new employees. The stock options were granted on July 15, 2021. The grants were ...

Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
 PRESS RELEASE
KALA Kala Pharmaceut... (Health Care)

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rul...

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 92,000 shares of Kala Pharmaceuticals common stock to sixteen new employees. The stock options were granted on July 15, 2021. The grants were ...

Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
 PRESS RELEASE
KALA Kala Pharmaceut... (Health Care)

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rul...

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 92,000 shares of Kala Pharmaceuticals common stock to sixteen new employees. The stock options were granted on July 15, 2021. The grants were ...

Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
 PRESS RELEASE
KALA Kala Pharmaceut... (Health Care)

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rul...

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 92,000 shares of Kala Pharmaceuticals common stock to sixteen new employees. The stock options were granted on July 15, 2021. The grants were ...

Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides
Liana Moussatos ... (+2)
  • Liana Moussatos
  • Andreas Argyrides

ResearchPool Subscriptions

Get the most out of your insights

Get in touch